
Shelley Elaine Wetsell (Wetsell) Crary MD MS
Pediatric Coagulation Disorder Hematology
Professor, Pediatrics, University of Arkansas for Medical Sciences
Join to View Full Profile
Arkansas Children's Hospital, Arkansas Children's Northwest, UAMS Medical Center1 Children's WayLittle Rock, AR 72202
Phone+1 501-263-2621
Dr. Crary is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2003 - 2006
- Vanderbilt University Medical CenterResidency, Pediatrics, 2000 - 2003
- Tulane University School of MedicineClass of 2000
Certifications & Licensure
- AR State Medical License 2011 - 2026
- TX State Medical License 2006 - 2011
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- The Dallas Hereditary Spherocytosis Cohort Study Start of enrollment: 2010 May 01
Publications & Presentations
PubMed
- The Functional Characterization of Venous Thromboembolic Disease (FUVID) study: rationale, design, and methods of a prospective, observational, multicenter study to ev...Ayesha Zia, Michael D Nelson, Jimin Ren, Song Zhang, Robert F Mattrey
Research and Practice in Thrombosis and Haemostasis. 2025-01-01 - 1 citationsInvasive procedures and surgery following etranacogene dezaparvovec gene therapy in people with hemophilia B.Niamh O'Connell, Paul van der Valk, Sandra Le Quellec, Esteban Gomez, Paul E Monahan
Journal of Thrombosis and Haemostasis. 2025-01-01 - 1 citationsWhat is in a name: defining pediatric refractory ITP.Taizo A Nakano, Amanda B Grimes, Robert J Klaassen, Michele P Lambert, Cindy Neunert
Blood Advances. 2024-10-08
Press Mentions
- ASC Therapeutics Doses First Patient with ASC618 Second-Generation Gene Therapy for Hemophilia ANovember 30th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: